Greg Myers

Greg Myers is a Research Fellow at the University of Michigan’s Department of Physics, affiliated with the Randall Laboratory and Homer A. Neal Lab. He focuses on interdisciplinary research at the intersection of physics and biomedical science, particularly investigating molecular mechanisms of hemoglobin regulation, anemia pathogenesis, and erythroid differentiation. His work leverages CRISPR-based screening technologies, small molecule inhibitors, and cellular models to explore therapeutic strategies for genetic blood disorders. Contact him via gregmyer@umich.edu or visit his office at 450 Church Street, Ann Arbor, MI 48109-1040.

His research interests include epigenetic regulation of γ-globin genes, metabolic pathways in erythropoiesis, and the role of protein complexes such as the SAGA complex in blood cell development. He employs advanced genomic and biochemical tools to uncover novel targets for diseases like sickle cell disease and Diamond-Blackfan anemia.

Greg Myers has contributed to studies on LSD1 inhibitors, TR4/BCL11A transcriptional repression, and lipid metabolism defects in anemia. His findings highlight potential therapeutic avenues through epigenetic modulation and genetic intervention. No scientific awards are explicitly mentioned in the text.

His advising involvement and grant details are not detailed in the provided text, though his research likely involves collaborations and funding from biomedical research institutions. The labs he is associated with specialize in both physics and applied biomedical research, fostering a unique environment for interdisciplinary studies.